Alto Neuroscience (ANRO) Times Interest Earned (2023 - 2026)
Alto Neuroscience's (ANRO) quarterly Times Interest Earned came in at -$49.79 in Q1 2026, down 89.95% year-on-year from -$495.64 in Q1 2025, and down 67.88% quarter-over-quarter from -$29.66 in Q4 2025.
Alto Neuroscience (ANRO) Times Interest Earned (2023 - 2026) Analysis & Trends
Alto Neuroscience has disclosed Times Interest Earned across 4 years of filings, most recently posting -$49.79 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$49.79, down 89.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$32.21 (up 25.02% YoY), and the FY2025 annual result was -$26.88, up 46.13% from the prior year.
- Times Interest Earned came in at -$49.79 for Q1 2026 at Alto Neuroscience, down from -$29.66 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$22.23 in Q1 2023 to a low of -$54.11 in Q3 2024.
- The 4-year median for Times Interest Earned is -$29.66 (2025), against an average of -$35.93.
- Across the five-year window, Times Interest Earned sank 102.14% in 2024 and surged 57.49% in 2025, its largest moves.
- Alto Neuroscience's Times Interest Earned stood at -$33.05 in 2023, then slumped by 54.45% to -$51.04 in 2024, then soared by 41.89% to -$29.66 in 2025, then sank by 67.88% to -$49.79 in 2026.
- The last three Times Interest Earned figures came in at -$49.79 (Q1 2026), -$29.66 (Q4 2025), and -$23.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -258.33 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 11.79 |
| 10 | Alto Neuroscience | 643.06 Mn | 379.30 Mn | - | -49.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.79 |
| Dec 31, 2025 | -29.66 |
| Sep 30, 2025 | -23.00 |
| Jun 30, 2025 | -28.92 |
| Mar 31, 2025 | -26.21 |
| Dec 31, 2024 | -51.04 |
| Sep 30, 2024 | -54.11 |
| Jun 30, 2024 | -52.86 |
| Mar 31, 2024 | -41.58 |
| Dec 31, 2023 | -33.05 |
| Sep 30, 2023 | -26.77 |
| Jun 30, 2023 | -27.91 |
| Mar 31, 2023 | -22.23 |